BENECCHI CHRISTOPHER (Chief Commercial Officer) received a stock award from SAGE THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 4/11/2025ACC: 0001562180-25-003114
Officer· Chief Commercial Officer
Since Sep 2021
+4.51K
Net shares
Net buyer
$10.0K
Total sold
0
Open market trades
0B · 0S
4
Total transactions
5.97K acquired · 1.45K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
+3.25K
Price / share
—
Trade value
—
% of position
7.4%
4/10/2025
43.91K→47.17K
Common Stock
Direct
Shares
−793.00
Price / share
$6.91
Trade value
$5.48K
% of position
1.7%
4/10/2025
47.17K→46.38K
Common Stock
Direct
Shares
+2.71K
Price / share
—
Trade value
—
% of position
5.8%
4/10/2025
46.38K→49.09K
Common Stock
Direct
Shares
−661.00
Price / share
$6.91
Trade value
$4.57K
% of position
1.3%
4/10/2025
49.09K→48.43K
Total
Net shares
+4.51K
Net value
-$10.05K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 4/10/2025 | A · Award | +3.25K | — | — | 7.4% | 43.91K | 47.17K |
| Common Stock Direct | 4/10/2025 | F · Tax Withholding | −793.00 | $6.91 | $5.48K | 1.7% | 47.17K | 46.38K |
| Common Stock Direct | 4/10/2025 | A · Award | +2.71K | — | — | 5.8% | 46.38K | 49.09K |
| Common Stock Direct | 4/10/2025 | F · Tax Withholding | −661.00 | $6.91 | $4.57K | 1.3% | 49.09K | 48.43K |
| Total | +4.51K | -$10.05K | ||||||
Derivative Transactions0
No derivative transactions reported